{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:19:59Z","timestamp":1790741999553,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]},{"name":"JSPS KAKENHI","award":["14446690"],"award-info":[{"award-number":["14446690"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.leukres.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T05:54:09Z","timestamp":1459662849000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["BCR\/ABL increases EZH2 levels which regulates XIAP expression via miRNA-219 in chronic myeloid leukemia cells"],"prefix":"10.1016","volume":"45","author":[{"given":"Chie","family":"Nishioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2016.03.012_bib0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1440-169X.2010.01191.x","article-title":"Role of the polycomb group proteins in hematopoietic stem cells","volume":"52","author":"Konuma","year":"2010","journal-title":"Dev. Growth Differ."},{"key":"10.1016\/j.leukres.2016.03.012_bib0010","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1035902","article-title":"Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of zeste protein","volume":"16","author":"Kuzmichev","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.leukres.2016.03.012_bib0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.leukres.2016.03.012_bib0020","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2016.03.012_bib0025","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2016.03.012_bib0030","doi-asserted-by":"crossref","first-page":"10657","DOI":"10.1158\/0008-5472.CAN-07-2498","article-title":"A polycomb repression signature in metastatic prostate cancer predicts cancer outcome","volume":"67","author":"Yu","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2016.03.012_bib0035","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/onc.2008.433","article-title":"Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1","volume":"28","author":"Gonzalez","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2016.03.012_bib0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccr.2010.06.016","article-title":"Regulation of tumor angiogenesis by EZH2","volume":"18","author":"Lu","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2016.03.012_bib0045","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1038\/bcj.2011.33","article-title":"Imatinib causes epigenetic alterations of PTEN gene via upregulation of DNA methyltransferases and polycomb group proteins","volume":"1","author":"Nishioka","year":"2011","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2016.03.012_bib0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.biocel.2012.10.009","article-title":"EZH2 is regulated by ERK\/AKT and targets integrin alpha2 gene to control epithelial-mesenchymal transition and anoikis in colon cancer cells","volume":"45","author":"Ferraro","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.leukres.2016.03.012_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.06.003","article-title":"Imatinib resistance in CML","volume":"274","author":"Volpe","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.leukres.2016.03.012_bib0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/14728214.2015.1031217","article-title":"Update on emerging treatments for chronic myeloid leukemia","volume":"20","author":"Fava","year":"2015","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.leukres.2016.03.012_bib0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00277-015-2323-1","article-title":"Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients","volume":"94","author":"Hochhaus","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2016.03.012_bib0070","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1535-7163.MCT-09-0013","article-title":"DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation","volume":"8","author":"Miranda","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.leukres.2016.03.012_bib0075","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.leukres.2016.03.012_bib0080","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1038\/oncsis.2014.17","article-title":"Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells","volume":"3","author":"Hibino","year":"2014","journal-title":"Oncogenesis"},{"key":"10.1016\/j.leukres.2016.03.012_bib0085","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.molmed.2006.10.006","article-title":"MicroRNA expression and function in cancer","volume":"12","author":"Garzon","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.leukres.2016.03.012_bib0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs\u2014microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.leukres.2016.03.012_bib0095","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.leukres.2016.03.012_bib0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2016.03.012_bib0105","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1038\/oncsis.2013.21","article-title":"Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions","volume":"2","author":"Menigatti","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.leukres.2016.03.012_bib0110","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.4161\/cc.6.12.4408","article-title":"CpG island hypermethylation of tumor suppressor microRNAs in human cancer","volume":"6","author":"Lujambio","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.leukres.2016.03.012_bib0115","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2016.03.012_bib0120","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.febslet.2013.05.054","article-title":"MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells","volume":"587","author":"Liu","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.leukres.2016.03.012_bib0125","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1038\/sj.onc.1203479","article-title":"The role of STATs in myeloid differentiation and leukemia","volume":"19","author":"Coffer","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2016.03.012_bib0130","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V86.2.726.bloodjournal862726","article-title":"Phosphatidylinositol-3 kinase activity is regulated by BCR\/ABL and is required for the growth of Philadelphia chromosome-positive cells","volume":"86","author":"Skorski","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.03.012_bib0135","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00432-012-1292-1","article-title":"Growth inhibitory effect of dihydroartemisinin on Bcr\/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-\u03baB modulation","volume":"138","author":"Lee","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.leukres.2016.03.012_bib0140","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.12.7.968","article-title":"A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation","volume":"12","author":"Reuther","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.leukres.2016.03.012_bib0145","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1093\/emboj\/16.20.6151","article-title":"Transformation of hematopoietic cells by BCR\/ABL requires activation of a PI-3k\/Akt-dependent pathway","volume":"16","author":"Skorski","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.leukres.2016.03.012_bib0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1101\/gad.1643908","article-title":"Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B","volume":"22","author":"Hennighausen","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.leukres.2016.03.012_bib0155","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.bi.64.070195.003201","article-title":"Transcriptional responses to polypeptide ligands: the JAK-STAT pathway","volume":"64","author":"Schindler","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.leukres.2016.03.012_bib0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nri2958","article-title":"Genomic views of STAT function in CD4+ T helper cell differentiation","volume":"11","author":"O\u2019Shea","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.leukres.2016.03.012_bib0165","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ijc.2910530318","article-title":"Phenotypic and molecular analysis of Ph1-chromosome-positive acute lymphoblastic leukemia cell lines","volume":"53","author":"Miyagi","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.leukres.2016.03.012_bib0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/stem.5530010205","article-title":"Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis","volume":"1","author":"Kubonishi","year":"1983","journal-title":"Int. J. Cell Cloning"},{"key":"10.1016\/j.leukres.2016.03.012_bib0175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cas.12339","article-title":"Downregulation of miR-217 correlates with resistance of ph(+) leukemia cells to ABL tyrosine kinase inhibitors","volume":"105","author":"Nishioka","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2016.03.012_bib0180","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1080372","article-title":"Vertebrate microRNA genes","volume":"299","author":"Lim","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.leukres.2016.03.012_bib0185","doi-asserted-by":"crossref","first-page":"10868","DOI":"10.18632\/oncotarget.3451","article-title":"microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2016.03.012_bib0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1158\/0008-5472.CAN-12-0255","article-title":"STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2","volume":"73","author":"Tam","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2016.03.012_bib0195","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1182\/blood-2006-08-039073","article-title":"STAT5A is required for long-term maintenance of normal and leukemic human tem\/progenitor cells","volume":"110","author":"Schepers","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.03.012_bib0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.exphem.2007.01.018","article-title":"Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells","volume":"35","author":"Moore","year":"2007","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.leukres.2016.03.012_bib0205","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood-2011-11-394932","article-title":"Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia","volume":"120","author":"Tanaka","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.03.012_bib0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2010.03.051","article-title":"Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells","volume":"637","author":"Hua","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.leukres.2016.03.012_bib0215","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3892\/or.2012.2033","article-title":"Downregulation of Ezh2 expression by RNA interference induces cell cycle arrest in the G0\/G1 phase and apoptosis in U87 human glioma cells","volume":"28","author":"Zhang","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.leukres.2016.03.012_bib0220","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1038\/sj.onc.1209390","article-title":"Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha","volume":"25","author":"Malinge","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2016.03.012_bib0225","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12032-009-9294-9","volume":"27","author":"Momeny","year":"2010","journal-title":"Med. Oncol."},{"key":"10.1016\/j.leukres.2016.03.012_bib0230","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1074\/jbc.M510863200","article-title":"The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases","volume":"281","author":"Eckelman","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2016.03.012_bib0235","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1179\/joc.2006.18.1.98","article-title":"Chemosensitization effects of XIAP downregulation in K562 leukemia cells","volume":"18","author":"Lima","year":"2006","journal-title":"J. Chemother."},{"key":"10.1016\/j.leukres.2016.03.012_bib0240","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1159\/000354520","article-title":"Berberine induces apoptosis in p53-null leukemia cells by down-regulating XIAP at the post-transcriptional level","volume":"32","author":"Liu","year":"2013","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616300406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616300406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T03:16:40Z","timestamp":1600399000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212616300406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":48,"alternative-id":["S0145212616300406"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2016.03.012","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCR\/ABL increases EZH2 levels which regulates XIAP expression via miRNA-219 in chronic myeloid leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}